Emerald Advisers, LLC Bridge Bio Pharma, Inc. Transaction History
Emerald Advisers, LLC
- $2.41 Billion
- Q3 2024
A detailed history of Emerald Advisers, LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Emerald Advisers, LLC holds 1,103,508 shares of BBIO stock, worth $25.4 Million. This represents 1.17% of its overall portfolio holdings.
Number of Shares
1,103,508
Previous 666,344
65.61%
Holding current value
$25.4 Million
Previous $16.9 Million
66.46%
% of portfolio
1.17%
Previous 0.76%
Shares
6 transactions
Others Institutions Holding BBIO
# of Institutions
291Shares Held
171MCall Options Held
10.4MPut Options Held
2.37M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$582 Million35.94% of portfolio
-
Viking Global Investors LP25.1MShares$579 Million2.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$327 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$287 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$140 Million63.58% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $3.42B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...